Remove Clinical Research Remove Clinical Trials Remove Doctors Remove Pharmacy
article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beyond blood tests: The evolution of digital biomarkers in clinical research

Drug Discovery World

Digital biomarkers promise to transform preventive medicine and clinical trials, but also raise issues of security, regulation and potential disparities in access. Deepika Khedekar, Clinical Trial Lead at IQVIA, provides an overview of the pros and cons, and suggests a possible solution.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

article thumbnail

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

UPMC did not allow patients to receive experimental COVID-19 therapies outside of the context of a clinical trial and used the REMAP-CAP platform, a global pragmatic adaptive trial platform, in all clinic sites. Clinicians wrote a consult for mABs and the pharmacy delivered whichever mAB that was available.

article thumbnail

A Q&A with Dr. Christine Senn: Chair, 2023 ACRP Board of Trustees

ACRP blog

As Christine Senn, PhD, CCRC, CPI, ACRP-CP, FACRP, Chief Integration Officer with Centricity Research, settles into her volunteer duties as the 2023 Chair of the Association Board of Trustees (ABoT) for ACRP, she took time to answer some questions about her outlook on the current state of the Association and the clinical research enterprise.

article thumbnail

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

About the Trial The RECOVERY trial is conducted by the registered clinical trials units in the Nuffield Department of Population Health in partnership with the Nuffield Department of Medicine. The DMC letter is available here: [link]. Department of Health and Human Services under OT number: HHSO100201700020C.

Trials 52